Hayat Pharmaceutical Industries Co. PLC reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JOD 15.81 million compared to JOD 17.11 million a year ago.

Net income was JOD 2.33 million compared to JOD 3.53 million a year ago. Basic earnings per share from continuing operations was JOD 0.25 compared to JOD 0.37 a year ago.